Is sugammadex economically viable for routine use

Thomas Fuchs-Buder*, Claude Meistelman, Jan U. Schreiber

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

19 Citations (Web of Science)
Original languageEnglish
Pages (from-to)217-220
JournalCurrent Opinion in Anesthesiology
Volume25
Issue number2
DOIs
Publication statusPublished - Apr 2012

Keywords

  • neostigmine
  • pharmacoeconomics
  • residual blockade
  • sugammadex

Cite this